Related Experiment Video
Updated: Jun 20, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Minimized extracorporeal circulation cannot prevent acute kidney injury but attenuates early renal dysfunction after
Claudius Diez1, Assad Haneya, Frank Brünger
1Department of Cardiothoracic Surgery, University Medical Centre Regensburg, Franz-Josef-Strauss-Allee 11,D-93053 Regensburg,Germany. claudius.diez@t-online.de
Insights
Minimized extracorporeal circulation (MECC) shows renoprotective effects post-cardiac surgery, reducing dialysis needs. However, MECC does not prevent acute kidney injury (AKI) in patients undergoing coronary bypass grafting.
Area of Science:
- Cardiovascular Surgery
- Nephrology
- Critical Care Medicine
Background:
- Coronary bypass grafting often involves cardiopulmonary bypass, which can lead to acute kidney injury (AKI).
- Minimized extracorporeal circulation (MECC) is an alternative to conventional extracorporeal circulation (ECC) with potential hemodynamic benefits.
Purpose of the Study:
- To evaluate the impact of MECC versus conventional ECC on the incidence of AKI after coronary bypass grafting.
- To assess the secondary outcome of temporary dialysis requirement and mortality risk associated with preoperative renal function.
Main Methods:
- Retrospective observational study involving 1,685 patients undergoing MECC and 3,046 patients undergoing conventional ECC.
- Primary outcome: AKI defined as a decline of >= 50% in estimated glomerular filtration rate (eGFR) within 48 hours post-surgery.
- Secondary outcomes: Temporary dialysis and 30-day mortality.
Main Results:
- Fewer patients in the MECC group experienced a decline in eGFR <60 mL/min/1.73 m(2) compared to the ECC group (30.7% vs. 45.5%, p < 0.001).
- The incidence of AKI (eGFR decrease >= 50%) did not significantly differ between groups (1.8% vs. 2.7%, p = 0.20).
- Temporary dialysis was required less often in the MECC group (0.9% vs. 2.0%, p < 0.001).
- Preoperative eGFR <60 mL/min/1.73 m(2) significantly increased mortality risk in both groups.
Conclusions:
- MECC demonstrates renoprotective effects in the early postoperative period after coronary bypass grafting, evidenced by reduced need for dialysis.
- MECC does not prevent the occurrence of acute kidney injury.
- Preoperative renal function impairment is a critical predictor of mortality, irrespective of the cardiopulmonary bypass system used.
Abstract:
We studied the impact of minimized extracorporeal circulation (MECC) on acute kidney injury (AKI) after coronary bypass grafting. A retrospective, observational study with 1,685 patients with MECC and 3,046 patients with conventional bypass was done. Primary outcome was AKI defined as a decline > or = 50% in estimated glomerular filtration rate (eGFR) within 48 hours after surgery. Secondary outcome was temporary dialysis. MECC exerts beneficial hemodynamic effects but does not prevent AKI. Fewer patients developed a decline in eGFR <60 mL/min/1.73 m(2) (MECC) compared with conventional extracorporeal circulation (ECC) (30.7% versus 45.5%, p < 0.001). The incidence of eGFR decrease by > or = 50% did not differ (1.8% versus 2.7%, p = 0.20). Temporary dialysis was required in 61 patients with ECC (2%) and in 16 patients with MECC (0.9%, p < 0.001). A preoperative eGFR <60 mL/min/1.73 m(2) increased in both groups the risk for mortality compared with patients with an eGFR >60 mL/min/1.73 m(2) (ECC: odds ratio 3.6, 95% confidence interval 2.6-4.9; MECC: odds ratio 4.9, 95% confidence interval 2.8-8.6). MECC is renoprotective in the early postoperative period but cannot prevent AKI. An impaired preoperative eGFR increases the risk for mortality irrespective of the cardiopulmonary bypass system used.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

